You are here

Technology transfer

20.11.2018

Increasing deal flow of projects ready for investment in the BioRegion: this is the main goal of the Investment Readiness Series, a new initiative from Biocat that periodically connects Catalan research projects with local and international investors. Some of the scientists participating in the first edition tell us about the projects they hope will enamor these investors.

30.10.2018

Clinical milestones, new launches and scientific awards round out the headlines in the BioRegion for October

26.09.2018

Baselga’s resignation serves as a bittersweet counterpoint to a September full of good news

25.09.2018

ABLE and iBreve, selected to extend their stay in the American city with a three week immersion program

ERC Proof of concept, IRB, CRG, UAB
17.09.2018

Projects from the IRB, CRG, and UAB have been chosen in the latest edition of grants from the European Research Council (ERC), each worth up to €150,000. Catalonia swept 10% of the total grants awarded to researchers from all over Europe and 5 of the 7 grants awarded to Spanish entities.

tips from boston for healthcare entrepreneurs CIMIT Biocat
23.04.2018

Who will pay for my product? Who can kill it? How do I approach investors? What happens if I fail? Experts from CIMIT (Boston), the most experienced health accelerator in the world, share some of the lessons they’ve learned accelerating more than 600 healthtech projects in 15 years.

 

CRAASH Barcelona kick off
18.04.2018

The program will continue with web meetings, market validation in Europe and a final presentation in Boston

CRAASHBarcelona
14.02.2018

Call is open until March 11 for projects from the medical device, diagnostics and e/digital health sector

CRAASH Barcelona From lab to market
23.01.2018

The new initiative will bring research of excellence to market with top experts from the Boston ecosystem

Health & Bio 2017
21.11.2017

The initiative organised by Banco Sabadell’s BStartup, Biocat and CataloniaBio brings together 160 meetings among scientists and executives